Notably, the GDScore achieved superior performance in differentiating IDH wild-type gliomas (AUC = 0.93) and IDH mutant gliomas (AUC = 0.94) from healthy controls in the validation set [96]. The gene discussed is IDH1; the disease is central nervous system cancer.